Despite the potential benefits, targeting CSCs presents several challenges. CSCs often share many characteristics with normal stem cells, making it difficult to target them specifically without causing damage to healthy tissues. Furthermore, the heterogeneity of CSCs within and between tumors complicates the development of universal CSC-targeted therapies. Identifying reliable CSC markers and understanding their biology in different cancer types are ongoing areas of research.
